Concepedia

Publication | Open Access

Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells

DOIFull Paper Access

48

Citations

53

References

2019

Year

Nicholas Jette, Suraj Radhamani, Greydon Arthur, Ruiqiong Ye, Siddhartha Goutam, Anthony Bolyos, Lars F. Petersen, Pinaki Bose, D. Gwyn Bebb, Susan P. Lees‐Miller
British Journal of Cancer

Abstract

Patients with tumours characterised by ATM-deficiency may benefit from treatment with a PARP inhibitor in combination with an ATR inhibitor.

References

YearCitations

Page 1